Early detection and prevention of endometrial and uterine cancer
Uterine (endometrial) cancer is the most common gynecologic cancer. When detected early, it is highly treatable. Our comprehensive screening program focuses on early detection and prevention, following international guidelines tailored to your age, risk factors, and medical history.
Regular screening can identify precancerous changes before they develop into cancer, significantly improving treatment outcomes and survival rates.
Comprehensive gynecologic history review and personal risk factor evaluation to determine your individual screening needs.
Thorough pelvic exam including transvaginal ultrasound to visualize the uterus and detect abnormalities.
When clinically indicated, endometrial biopsy provides definitive diagnosis of uterine conditions.
Excess body fat increases estrogen levels, which can stimulate endometrial growth.
Most cases occur in women over 50, particularly during and after menopause.
Genetic predisposition including Lynch syndrome increases risk significantly.
Early menstruation, late menopause, or estrogen-only hormone therapy.
Polycystic Ovary Syndrome causes hormonal imbalances that increase risk.
Breast cancer treatment medication can increase uterine cancer risk.
If you experience any of these symptoms, schedule a consultation with our gynecology team immediately.